Blar i forfatter "Krieger, Ekaterina Anatoljevna"

Viser treff 1-3 av 3

    • COVID-19: seroprevalence and adherence to preventive measures in Arkhangelsk, Northwest Russia 

      Krieger, Ekaterina Anatoljevna; Sharashova, Ekaterina; Kudryavtsev, Alexander V; Samodova, Olga; Kontsevaya, Anna; Brenn, Tormod; Postoev, Vitaly (Journal article; Tidsskriftartikkel, 2023-03-15)
      Background - The published estimates of SARS-CoV-2 seroprevalence in Russia are few. The study aimed to assess the SARS-CoV-2 seroprevalence in Arkhangelsk (Northwest Russia), in a year after the start of the pandemic, to evaluate the population adherence to non-pharmaceutical interventions (NPIs), and to investigate characteristics associated with COVID-19 seropositive status.<p> <p>Methods - ...

    • Prevalence assessment adjusted for laboratory test performance using an example of the COVID-19 serological tests 

      Krieger, Ekaterina Anatoljevna; Grjibovski, Andrej; Postoev, Vitaly A. (Journal article; Tidsskriftartikkel; Peer reviewed, 2022-07-19)
      Assessment of the prevalence of the disease or condition should consider the accuracy of the diagnostic tests. In the context of the new coronavirus infection (COVID-19) pandemic, laboratory testing has been one of the most important components of the overall strategy for the control and prevention of this infection. Seroprevalence studies have been used to assess and monitor the level of population ...

    • Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia 

      Krieger, Ekaterina Anatoljevna; Kudryavtsev, Alexander V; Sharashova, Ekaterina; Postoev, Vitaly; Belova, Natalia; Shagrov, Leonid; Zvedina, Julia; Drapkina, Oxana; Kontsevaya, Anna; Shalnova, Svetlana; Brenn, Tormod; Shkolnikov, Vladimir M.; Eggo, Rosalind M.; Leon, David Adrew (Journal article; Tidsskriftartikkel; Peer reviewed, 2022-02)
      Population-based data on coronavirus disease in Russia and on the immunogenicity of the Sputnik V vaccine are sparse. In a survey of 1,080 residents of Arkhangelsk 40–75 years of age, 65% were seropositive for IgG. Fifteen percent of participants had been vaccinated; of those, 97% were seropositive.